Basal insulin glargine and microvascular outcomes in dysglycaemic individuals: Results of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial

Diabetologia

Volumn 57, Issue 7, 2014, Pages 1325-1331

  Gilbert, Richard E ^a,b   Mann, Johannes F E ^c   Hanefeld, Markolf ^d   Spinas, Giatgen ^e   Bosch, Jackie ^f   Yusuf, Salim ^f,g   Gerstein, Hertzel C ^f,g  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f MCMASTER UNIVERSITY   (Canada)

^g MCMASTER UNIVERSITY   (Canada)

Author keywords

Albuminuria; Diabetic nephropathy; Insulin glargine; Microvascular; Retinopathy

Indexed keywords

ALBUMIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN GLARGINE; OMEGA 3 FATTY ACID; PLACEBO; ANTIDIABETIC AGENT; GLARGINE; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; LONG ACTING INSULIN;

ADULT; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIET RESTRICTION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; KIDNEY FAILURE; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VITRECTOMY; AGED; BLOOD; COMPLICATION; DIABETES MELLITUS, TYPE 2; GLUCOSE INTOLERANCE; MIDDLE AGED; TREATMENT OUTCOME;

AGED; ALBUMINURIA; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN, LONG-ACTING; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84903514868     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3238-4     Document Type: Article

References (12)

1. (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197
2. Krolewski AS, Laffel LM, Krolewski M, Quinn M, Warram JH (1995) Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetesmellitus.N Engl JMed 332:1251-1255
3. Raskin P, Rosenstock J (1986) Blood glucose control and diabetic complications. Ann Intern Med 105:254-263 (Pubitemid 16039305)
4. Stratton IM, Adler AI, Neil HA et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405-412 (Pubitemid 30609442)
5. Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-termcomplications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
6. Patel A, MacMahon S, Chalmers J et al (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:2560-2572 (Pubitemid 351831357)
7. Ismail-Beigi F, Craven T, BanerjiMA et al (2010) Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 376:419-430
8. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853
9. ORIGIN Trial Investigators, Gerstein HC, Bosch J et al (2012) Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med 367:319-328
10. ORIGIN Trial Investigators, Bosch J, Gerstein HC et al (2012) n-3 fatty acids and cardiovascular outcomes in patientswith dysglycemia. N Engl J Med 367:309-318
11. Origin Trial Investigators, Gerstein H, Yusuf S et al (2008) Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention). Am Heart J 155:26-32
12. Zoungas S, Chalmers J, Ninomiya T et al (2012) Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia 55:636-643